Amir Sharifi-Sistani,Ali Tafazoli
Amir Sharifi-Sistani
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine [0.03%]
抗精神病药治疗精神分裂症的疗效和安全性：重点关注氯丙嗪的不良反应
Domenico De Berardis,Gabriella Rapini,Luigi Olivieri et al.
Domenico De Berardis et al.
Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant schizophr...
Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined [0.03%]
乳糖不耐受患者的急性疼痛管理：重新评估一种老辅料的安全性
Deanna Mill,Jessica Dawson,Jacinta Lee Johnson
Deanna Mill
Lactose intolerance is exceedingly common, reportedly affecting up to 70% of the world's population, leading to both abdominal and systemic symptoms. Current treatment focuses predominantly on restricting dietary consumption of lactose. Giv...
Amber Onoh,Sunny A Linnebur,Danielle R Fixen
Amber Onoh
An increased risk of bacterial resistance toward fluoroquinolones and the increased risk of disabling and serious adverse effects prompted the US Food and Drug Administration to recommend limiting fluoroquinolone use to the treatment of com...
Trigger alerts associated with laboratory abnormalities on identifying potentially preventable adverse drug events in the intensive care unit and general ward [0.03%]
基于实验室异常触发警报以识别重症监护室和普通病房中潜在可预防的药物不良事件
Mitchell S Buckley,Jeffrey R Rasmussen,Dale S Bikin et al.
Mitchell S Buckley et al.
Background: Medication safety strategies involving trigger alerts have demonstrated potential in identifying drug-related hazardous conditions (DRHCs) and preventing adverse drug events in hospitalized patients. However, ...
Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia [0.03%]
澳大利亚市场塞来昔布和埃托菲的不良反应报告分析
Carmen Abeyaratne,Samanta Lalic,J Simon Bell et al.
Carmen Abeyaratne et al.
Background: The rapid increase in prescribing and use of opioids for noncancer pain has coincided with an increase in opioid-related adverse drug events (ADEs). The objective of our study was to describe ADEs related to t...
Excipient of medication the probable cause of urticaria in a boy with autism [0.03%]
-autism患儿药物辅料可能是荨麻疹的病因
Anne M Euser,Catrien G Reichart,Ingrid D C van Balkom
Anne M Euser
Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients [0.03%]
老年住院患者口服抗凝药物的潜在相互作用事件分析
Heather L Forbes,Thomas M Polasek
Heather L Forbes
Background: To determine the prevalence and nature of potential drug-drug interactions (DDIs) with direct oral anticoagulants (DOACs) in elderly hospitalized patients. ...
A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease [0.03%]
通过分离慢性肾脏病贫血患者血红蛋白增长速率的影响，揭示了一个阈值轨迹
Gregory Fusco,Ali Hariri,Carlos Vallarino et al.
Gregory Fusco et al.
Background: To assess cardiovascular risk among various hemoglobin (Hb) rates of rise (RoR) in chronic kidney disease (CKD) patients with anemia who have initiated therapy with erythropoiesis stimulating agents (ESAs). ...
Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians [0.03%]
住院儿童药物使用错误上报情况的调查——护士和医生的观点差异分析
Rikke Mie Rishoej,Jesper Hallas,Lene Juel Kjeldsen et al.
Rikke Mie Rishoej et al.
Background: Hospitalized children are at risk of medication errors (MEs) due to complex dosage calculations and preparations. Incident reporting systems may facilitate prevention of MEs but underreporting potentially unde...